Obstructive Sleep Apnea in Pregnancy
Public ClinicalTrials.gov record NCT02383706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Obstructive Sleep Apnea in Pregnancy: Development of a Pregnancy-Specific Screening Tool
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Obstructive sleep apnea (OSA) is a risk factor for complications during pregnancy and current screening tools for OSA have not been shown to be reliable in pregnant women. The primary aim of this study is to develop a valid screening tool to identify at-risk pregnant women, so that they can be further evaluated and treated. Women with OSA may also be at risk for respiratory complications related to opiate administration for post-cesarean delivery pain. A secondary aim of this study is to evaluate post-operative minute ventilation in women who undergo cesarean delivery using a novel method of non-invasive minute ventilation monitoring.
Study identification
- NCT ID
- NCT02383706
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
- ApneaLink Air Device
- Berlin Quesionnaire Behavioral
- Epworth Sleepiness Scale Behavioral
- STOP-BANG questionnaire Behavioral
- Physical exam Other
Device · Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Apr 30, 2017
- Completion
- Jul 31, 2017
- Last update posted
- Jun 18, 2019
2015 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Sleep Apnea, Obstructive trials
Other public records listing Sleep Apnea, Obstructive. Sorted by last update posted; newest first. Not a recommendation.
- NCT00695214: Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea Recruiting
- NCT03860233: Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine Recruiting
- NCT07559708: A Study of the Sleepnet Elara APAP Device Not yet recruiting
- NCT05382754: Home Apnea Testing in CHildren Trial Recruiting
- NCT06789770: Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep Recruiting
- NCT06677151: NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02383706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2019 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02383706 live on ClinicalTrials.gov.